Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management NCR Atleos NATL Q1 2026 Earnings EPS Misses Estimates as Margins Face Pressure Destination XL Group Inc DXLG Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction DVS Q4 2025 Earnings Silver Developer Reports WiderThanExpected Loss Amid PreRevenue Phase APP Q1 2026 Earnings EPS Beat by 355 Despite Minor Stock Dip SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally